S 3564119th CongressIn Committee

NIH Clinical Trial Integrity Act

Standard Summary
Balanced plain-English summary

The NIH Clinical Trial Integrity Act would require NIH-funded researchers conducting clinical trials on drugs, devices, biologics, or behavioral interventions to submit recruitment and retention goals reflecting race, ethnicity, age, and sex, along with plans to meet those goals. It also requires demographic and retention reporting, researcher training on diversity, a study on cost barriers and reimbursement, and a national public education campaign with grants.

Key Points

  • 1Requires NIH-funded clinical trials to set measurable diversity recruitment and retention goals.
  • 2Mandates annual reporting on participant demographics and retention while protecting privacy.
  • 3Directs NIH to study cost barriers, reimbursement, compensation, and anti-kickback safe harbor issues.
  • 4Creates a national awareness campaign and grants to community groups to promote diverse trial participation.
  • 5Authorizes $10 million annually for fiscal years 2026 through 2029 for the campaign.

Impact Areas

NIH-funded research institutionsClinical trial sponsors and researchersUnderrepresented patient populationsHHS and NIHCommunity-based organizations
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026